Parkinsons Alzheimers.pptx Flashcards
Which are PARKINSONS drugs
a. levodopa
b. rivastigmine
c. carbidopa
d. entacapone
e. donepezil
f. pramiprexole/ ropinirole
g. benztropine
h. memantine
i. bromocriptine/apomorphine
a. levodopa
c. carbidopa
d. entacapone
f. pramiprexole/ ropinirole
g. benztropine
i. bromocriptine/apomorphine
Which are ALZHEIMERS drugs
a. levodopa
b. rivastigmine
c. carbidopa
d. entacapone
e. donepezil
f. pramiprexole/ ropinirole
g. benztropine
h. memantine
i. bromocriptine/apomorphine
b. rivastigmine
e. donepezil
h. memantine
Is there a cure for PARKINSONS?
Yes or no
No
PARKINSONS Symptoms T R A P B
Tremor Rigidity Akinesia Posterier Instability Bradykinesia
Parkinson’s Pathophysiology
- ? of dopamine neurons
a. Gain
b. Loss
b. Loss
Parkinson’s Pathophysiology Where are these dopamine neurons destroyed? In Order a. Basal Ganglia b.Substantia Nigra c. Extra Pyramidal System (EPS)
b. Substantia Nigra
a. Basal Ganglia
c. Extra Pyramidal System (EPS)
Which has Acetylcholine◦Dopamine?
a. Basal Ganglia
b. Substantia Nigra
c. Extra Pyramidal System (EPS)
a. Basal Ganglia
Which causes Parkinson’s
a. High Acetylcholine + High Dopamine
b. Low Acetylcholine + High Dopamine
c. High Acetylcholine + Low Dopamine
c. High Acetylcholine + Low Dopamine
PARKINSONS
Symptoms do not typically appear until ? neurons destroyed?
a. 80
b. 90
a. 80
Precursor of Dopamine= ?
a. K-Dopa
b. L-Dopa
b. L-Dopa
Treats: Parkinson's Restless Legs Syndrome (off label) a. levodopa +carbidopa (L-Dopa + carbidopa) b. rivastigmine c. carbidopa d. entacapone e. donepezil f. pramiprexole/ ropinirole g. benztropine h. memantine i. bromocriptine/apomorphine
a. levodopa +carbidopa
L-Dopa
Which INHIBITS the peripheral breakdown (before it crosses the Blood Brain Barrier) of levodopa to allow more L-Dopa to get into the brain?
a. levodopa +carbidopa (L-Dopa + carbidopa)
b. rivastigmine
c. carbidopa
d. entacapone
e. donepezil
f. pramiprexole/ ropinirole
g. benztropine
h. memantine
i. bromocriptine/apomorphine
c. carbidopa
Why we do not use L- Dopa as a monotreatment?
a. We can
b. 91-93 % goes to the brain
c. 1-3% goes to the brain
c. 1-3% goes to the brain
Which will a Parkinson’s patient experience While on Dopamine Medications?
a. TROUGH/ Wearing Off Phenomenon
b. Honeymoon period
c. On/OffPhenomenon
d. All
d. All
Al dopamine Med cause ?
a. Nausea and vomiting
b. Psychosis/Agitation/Hallucinations
c. Drowsiness
d. Melanoma
e. Impulse Control Issues
f. Postural/orthostatic hypotension
g. Hyper sexuality, gambling behavior
h. Tachycardia/Palpitations
a. Nausea and vomiting
f. Postural/orthostatic hypotension
h. Tachycardia/Palpitations
In Dopamine Precursor/Replacements- ADVERSE EFFECTS◦Peripheral ( (Central- inside the BBB))
a. Nausea and vomiting
b. Psychosis/Agitation/Hallucinations
c. Drowsiness
d. Melanoma
e. Impulse Control Issues
f. Postural/orthostatic hypotension
g. Hyper sexuality, gambling behavior
h. Tachycardia/Palpitations
a. Nausea and vomiting
b. Psychosis/Agitation/Hallucinations
c. Drowsiness
d. Melanoma
e. Impulse Control Issues
g. Hyper sexuality, gambling behavior
What is true about DYSKINESIAS
a. If you give not enough L-Dopa, it can PEAK inside the brain
b. If you give too much L-Dopa, it can PEAK inside the brain
c. Not enough causes more affinity for D2 receptors in substantia nigra
d. Too much- loses affinity for D2 receptors in substantia nigra
e. Will not bind to other receptors in the EPS
f. May bind to other receptors in the EPS
b. If you give too much L-Dopa, it can PEAK inside the brain
d. Too much- loses affinity for D2 receptors in substantia nigra
f. May bind to other receptors in the EPS
Which is important to tell a patient?- L-Dopa + Carbidopa
a. Educate patients- GI effects are common
b. Educate patients- GI effects are not common
c. Take with food to induce (yes protein)
d. Take with food to reduce (no protein)
e. L-Dopa can cause dyskinesias
f. Reduce dose or add medications to treat dyskinesias
g. discoloration of urine/sweat/bodily fluids
h. unusual sleepiness
i. Report any skin lesions as L-Dopa has been linked with j. activation of melanomas
a. Educate patients- GI effects are common
d. Take with food to reduce (no protein)
e. L-Dopa can cause dyskinesias
f. Reduce dose or add medications to treat dyskinesias
g. discoloration of urine/sweat/bodily fluids
h. unusual sleepiness
i. Report any skin lesions as L-Dopa has been linked with j. activation of melanomas
Patients should notice improvements over several weeks with - L-Dopa + Carbidopa what true?
a. Improved sense of well-being
b. Decreased concentration
c. Increased appetite
d. Decreased appetite
e. Improved ability to think and concentrate
f. Induced TRAP symptoms
g. Reduced TRAP symptoms
a. Improved sense of well-being
c. Increased appetite
e. Improved ability to think and concentrate
g. Reduced TRAP symptoms
Is it true that Parkinson‘s patient should stay hydrated because of the medication. T/F
No because of the disease
Which drugs are dopamine agonist drugs?
a. levodopa
b. rivastigmine
c. carbidopa
d. entacapone
e. donepezil
f. pramiprexole/ ropinirole
g. benztropine
h. memantine
i. bromocriptine/apomorphine
f. pramiprexole/ ropinirole
i. bromocriptine/apomorphine